There is no question that our nation’s health care system requires substantial reform. The status quo of soaring health care costs, struggling families, and health care provider shortages across Maine and the nation is unacceptable. Senator Collins frequently works with her colleagues on both sides of the aisle to address these and other important issues facing our nation such as improved mental health care, drug treatment programs, supporting America’s caregivers, and nutrition programs.

As a native to northern Maine, Senator Collins understands the specific challenges that rural communities face for medical care. Throughout her time in the Senate, Senator Collins has consistently supported programs to expand access to and improve the health care system, particularly for citizens living in rural areas. 

As a freshman legislator, Senator Collins founded the Senate Diabetes Caucus and has since led the effort to more than triple federal funding for diabetes research.

Senator Collins Joins Bipartisan Group in Calling for Inspector General Investigation into VA’s Failure to Pay Veterans Full Benefits

Washington, D.C. – U.S. Senator Susan Collins joined a bipartisan group of lawmakers in calling for a Department of Veterans Affairs (VA) Inspector General investigation into allegations that the VA would not reimburse veterans for misused or underpaid benefits.


In their bipartisan letter to the VA’s Inspector General, the lawmakers ask about how the technical errors occurred, how quickly any reimbursements will be made, and how the VA plans to make sure all benefits will continue to be paid out without interruption.



Senate Committee Unanimously Passes Bipartisan Bill to Fight Alzheimer’s

Washington, D.C. – Today, the Senate Health Committee unanimously passed the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act, legislation authored by U.S. Senators Susan Collins (R-ME), Catherine Cortez Masto (D-NV), Shelley Moore Capito (R-WV), and Tim Kaine (D-VA).  This bipartisan bill would create a public health infrastructure to combat Alzheimer’s disease and preserve brain health. 



Collins, King Announce Over $11 Million for Community Health Centers in Washington, Kennebec, Penobscot and Cumberland Counties

WASHINGTON D.C – U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) today announced that the U.S. Department of Health and Human Services (HHS) awarded a total of $11,668,486 for four community health centers throughout Maine. The funding will be awarded to Regional Medical Center in Lubec, Healthreach Community Health Centers in Waterville, Health Access Network Inc. in Lincoln, and Portland Community Health Center to improve health services and support health care professionals.



Senators Collins, King Announce $566,690 to Strengthen Rural Maine’s Response to Opioid Abuse

WASHINGTON, D.C. – U.S. Senators Susan Collins (R-Maine) and Angus King (I-Maine) announced today that the United States Department of Agriculture (USDA) has awarded $566,690 to two rural health care organizations in Maine as part of USDA’s Distance Learning and Telemedicine (DLT) Grant Program. The funding will help the organizations purchase network, video-conferencing, and other telecommunications equipment for rural health care facilities that specialize in addressing opioid abuse, treatment, and recovery.



Senators Collins, King Announce Maine Tribes Receive $440,011 in Opioid and Healthcare Grants

WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King announced today that four Maine Native communities will receive a total of $440,011 in funding from the Department of Health and Human Services (DHHS) to respond to substance abuse and jumpstart community health projects. These four grants will primarily address the impact of the opioid epidemic on Maine’s Native communities.



Bipartisan Legislation Authored by Senators Collins, McCaskill to Prohibit Pharmacy “Gag Clauses” Signed into Law

Washington, D.C. – Today, bipartisan legislation authored by U.S. Senators Susan Collins (R-ME) and Claire McCaskill (D-MO) to ban the use of pharmacy “gag clauses” was signed into law.  The Patient Right to Know Drug Prices Act prohibits an egregious practice that concealed lower prescription drug prices from patients at the pharmacy and caused consumers to needlessly overpay.  This legislation is a continuation of Senators Collins and McCaskill’s bipartisan efforts to reduce the cost of prescription drugs.



Senator Collins Votes to Protect Individuals with Pre-Existing Conditions

Legislation Senators Collins and Alexander introduced earlier this year would have lowered insurance premiums and expanded coverage while protecting those with pre-existing conditions


Washington, D.C. – Today, U.S. Senator Susan Collins (R-ME), the Chairman of the Senate Aging Committee and a member of the Health Committee, voted to block a rule that expands the duration of short-term health insurance plans, which could deny coverage to people with pre-existing conditions.



Senators Collins, King Announce Nearly $5 Million for Maine Organizations Those with Substance Use and Mental Health Disorders

Washington, D.C.—U.S. Senators Susan Collins and Angus King announced today that 17 community health centers in Maine will receive a total of $4,980,138 through the Health Resources and Services Administration (HRSA) Expanding Access to Quality Substance Use Disorder and Mental Health Services (SUD-MH) awards.  This funding will better equip health centers to help individuals and families overcome substance use disorders and improve mental health.  



Senators Collins, King Announce $840,000 in Funding to Support Seniors Managing Chronic Diseases

Washington, D.C. – U.S. Senators Susan Collins (R-ME) and Angus King (I-ME) announced that the Department of Health and Human Services’ Administration on Community Living (ACL) has awarded $840,000 to Healthy Living for ME, a partnership between three Area Agencies on Aging – Spectrum Generations, SeniorsPlus, and Aroostook Agency on Aging – to support chronic disease self-management education programs. 


Senator Collins’ Statement on Administration Examining Drug Importation to Lower Prescription Drug Prices

Washington, D.C. - U.S. Senator Susan Collins issued this statement following today’s announcement by the Administration that it is exploring how to safely import prescription drugs from other countries in the event of a dramatic price increase for a drug produced by one manufacturer and not protected by a patent.  Department of Health and Human Services Secretary Alex Azar asked Food and Drug Administration Commissioner Scott Gottlieb to establish a working group on this topic.


Senators Collins, King Announce Jackson Laboratory to Receive $4.1 Million Over Five Years to Research Alzheimer’s Disease

WASHINGTON, D.C. – Today, U.S. Senators Susan Collins (R-Maine), the founder and co-chair of the Congressional Task Force on Alzheimer’s disease, and Angus King (I-Maine) announced that The Jackson Laboratory in Bar Harbor has been awarded $873,647 for the year to study the progression and genetic causes of Alzheimer’s. The award is a part of a five-year allocation that will ultimately amount to $4,191,258 by 2023. The funds were awarded by the U.S. Department of Health and Human Services’ (DHHS) National Institute on Aging.




Subscribe to Health Care